| Model Instance Name: | |||||||||||
| #REF! | underlined & italicized: RE-ORDER | ||||||||||
| #REF! | pink: ADDITION | ||||||||||
| Date: | 8.11.2010 | blue + -->: REWORDING | |||||||||
| #REF! | |||||||||||
| QID | Skip Logic Label | Question Text | Answer Choices (limited to 50 characters) |
Skip to | Type (select from list) | Single or Multi | Required Y/N |
Special Instructions | CQ Label | ||
| EDO05135 | Is the frequency of the FDA email alerts appropriate? | Yes, the frequency is fine | Drop down, select one | Single | Y | Frequency | |||||
| I would like to receive it more often. | |||||||||||
| I would like to receive it less often. | |||||||||||
| EDO05136 | When would you like to receive email alerts? | During the week business hours only | Drop down, select one | Single | Y | Time | |||||
| During the week business and evening hours | |||||||||||
| During the week business and evening hours and on weekends | |||||||||||
| EDO05137 | Which of the following best describes your role? | Physician | Radio button, one-up vertical | Single | Y | OPS Group | Role | ||||
| Pharmacist/Pharmacy technician | |||||||||||
| Nurse/Nurse Practitioner | |||||||||||
| Physician Assistant | |||||||||||
| Medical resident or fellow | |||||||||||
| Medical, pharmacy, nursing, or allied health professional student | |||||||||||
| Medical Informatics/librarian in health system setting | |||||||||||
| Medical information provider/reporter | |||||||||||
| Consumer (not healthcare professional/student) | |||||||||||
| Other (please specify) | A | ||||||||||
| EDO05138 | A | Please describe your role: | Text area, no char limit | N | OPS Group | Other Role | |||||
| EDO05139 | Which of the following best describes your primary work setting? | Department of Defense (DOD) or Veteran's Affairs (VA) | Radio button, one-up vertical | Single | Y | OPS Group | Work Environment | ||||
| Other government agency | |||||||||||
| Private practice; self-employed | |||||||||||
| Community-based small group (less than 5 practitioners) | |||||||||||
| Multi-specialty group practice, Health Maintenance Organization (HMO) | |||||||||||
| Academic medical center | |||||||||||
| Community hospital | |||||||||||
| Academia | |||||||||||
| Pharmaceutical, device, or biological industry | |||||||||||
| Retail pharmacy | |||||||||||
| Investment firm | |||||||||||
| News media | |||||||||||
| Other (please specify) | B | ||||||||||
| EDO05140 | B | Please describe your primary work setting: | Text area, no char limit | N | OPS Group | Other Environment | |||||
| Please select your level of agreement with the following statements about the MedWatch Safety Alert emails? | Single | Y | Matrix Group | ||||||||
| EDO05141 | There is an adequate amount of detail provided in the subject line | Agree | Email Details | ||||||||
| Somewhat Agree | |||||||||||
| Disagree | |||||||||||
| EDO05142 | The audience identified in the email is accurate (accurately identifies for whom the information is relevant). | Agree | Email Relevance | ||||||||
| Somewhat Agree | |||||||||||
| Disagree | |||||||||||
| EDO05143 | The length of the email is appropriate | Agree | Email Length | ||||||||
| Somewhat Agree | |||||||||||
| Disagree | |||||||||||
| EDO05144 | There is enough information provided for me to take action on (if necessary) | Agree | Email Info | ||||||||
| Somewhat Agree | |||||||||||
| Disagree | |||||||||||
| EDO05145 | The supplemental links provided in the email are useful | Agree | Email Links | ||||||||
| Somewhat Agree | |||||||||||
| Disagree | |||||||||||
| EDO05146 | How do you use the MedWatch Safety Alert email information you receive? (Please select all that apply) | To stay current on medical product safety | Radio button, one-up vertical | Multi | Y | OPS Group | Usage | ||||
| To inform other colleagues and/or patients | |||||||||||
| To present new information at my committee meetings | |||||||||||
| To publish the information in professional newsletters | |||||||||||
| To add content to my organization's web site | |||||||||||
| To update drug information in my organization's electronic formulary or Electronic Medical Record (EMR) | |||||||||||
| Other (please specify) | C | ||||||||||
| EDO05147 | C | Please describe how you use the MedWatch Safety Alert email information you receive? | Text area, no char limit | N | OPS Group | Other Usage | |||||
| EDO05148 | On average, with how many individuals in your organization do you share MedWatch Safety Alert emails information with? | Zero | Radio button, one-up vertical | Single | Y | Forward On | |||||
| 1-5 people | |||||||||||
| 6-10 people | |||||||||||
| 11-20 people | |||||||||||
| 21-50 people | |||||||||||
| 51-100 people | |||||||||||
| 101-499 people | |||||||||||
| More than 500 people | |||||||||||
| EDO05149 | Which of the following product-specific emails are you interested in receiving? (Please select all that apply) | Drugs and Biologics (Prescription and over-the-counter) | Radio button, one-up vertical | Multi | Y | OPS Group | Product Center | ||||
| Medical devices (e.g. stents, implants, radiological products, diagnostics) | |||||||||||
| Blood, blood products and tissue | |||||||||||
| Vaccines | |||||||||||
| Dietary supplements | |||||||||||
| Food allergens | |||||||||||
| Food-related outbreaks | |||||||||||
| Cosmetics | |||||||||||
| Other (please specify) | D | ||||||||||
| EDO05150 | D | Please describe the other product specific emails you would like to receive: | Text area, no char limit | N | OPS Group | ||||||
| EDO05151 | Which of the following types of information are you interested in receiving? (Please select all that apply) | Emerging safety information about human medical products | Radio button, one-up vertical | Multi | Y | OPS Group | Information Topic | ||||
| Labeling changes with associated "Dear Healthcare Professional" letter issued by manufacturer | |||||||||||
| Recalls of drugs with a potential for serious injury or death | |||||||||||
| Recalls of medical devices with a potential for serious injury or death | |||||||||||
| Notices of safety issues related to off label or inappropriate use of drugs or devices | |||||||||||
| Safety information about newly approved drugs | |||||||||||
| Counterfeit medical products | |||||||||||
| Other (please specify) | E | ||||||||||
| EDO05152 | E | Please describe the other types of information you would like to receive: | Text area, no char limit | N | OPS Group | ||||||
| EDO05153 | Which of the following audience specific emails would you like to receive? (Please select all that apply) | General health professionals (e.g., Pharmacists, Nurses, Physicians) | Radio button, one-up vertical | Multi | OPS Group | Audience | |||||
| Medical specialty audiences (e.g. Urology, Oncology) | |||||||||||
| General public | |||||||||||
| Other (please specify) | F | ||||||||||
| EDO05154 | F | Please describe the audience you would like to receive emails for: | Text area, no char limit | OPS Group | |||||||
| EDO05155 | How else would you like to receive or access MedWatch Safety Alerts or MedWatch information about Monthly Drug Safety Labeling Changes? (Please select all that apply) | Text messages on my mobile phone | Radio button, one-up vertical | Multi | OPS Group | ||||||
| Audio (i.e. Podcast) | |||||||||||
| Video (i.e. YouTube | |||||||||||
| Blogs | |||||||||||
| MySpace | |||||||||||
| GoogleWave | |||||||||||
| Other (please specify) | G | ||||||||||
| EDO05156 | G | Other ways to access or receive information: | Text area, no char limit | ||||||||
| EDO05157 | What is the one improvement you would like MedWatch Safety Alerts to make to their emails? | Text area, no char limit | One Improvement | ||||||||
| File Type | application/vnd.openxmlformats-officedocument.spreadsheetml.sheet |
| File Modified | 0000-00-00 |
| File Created | 0000-00-00 |